Free Trial

Amundi Purchases 7,370 Shares of American Healthcare REIT, Inc. $AHR

American Healthcare REIT logo with Finance background

Key Points

  • Amundi increased its stake in American Healthcare REIT by 9.1%, acquiring an additional 7,370 shares, bringing its total holdings to approximately 88,515 shares valued at $2,691,000.
  • Invesco Ltd. and Vanguard Group also significantly boosted their stakes in American Healthcare REIT, with Invesco increasing its holdings by 1,543.1% and Vanguard by 22.4% during the first quarter.
  • American Healthcare REIT reported a Q2 EPS of $0.42, exceeding analyst estimates, and recently announced a quarterly dividend of $0.25 per share, with a yield of 2.3%.
  • Interested in American Healthcare REIT? Here are five stocks we like better.

Amundi lifted its holdings in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 9.1% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 88,515 shares of the company's stock after acquiring an additional 7,370 shares during the period. Amundi owned approximately 0.06% of American Healthcare REIT worth $2,691,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of AHR. Invesco Ltd. grew its stake in shares of American Healthcare REIT by 1,543.1% in the first quarter. Invesco Ltd. now owns 5,022,455 shares of the company's stock valued at $152,180,000 after acquiring an additional 4,716,792 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of American Healthcare REIT by 22.4% in the first quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company's stock valued at $569,494,000 after acquiring an additional 3,437,861 shares in the last quarter. Nuveen LLC acquired a new position in shares of American Healthcare REIT in the first quarter valued at about $68,097,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of American Healthcare REIT in the first quarter valued at about $13,384,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in American Healthcare REIT by 115.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 767,365 shares of the company's stock worth $21,809,000 after buying an additional 410,868 shares in the last quarter. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Trading Down 1.1%

Shares of AHR stock opened at $42.70 on Friday. The stock's fifty day moving average price is $39.86 and its two-hundred day moving average price is $34.91. The company has a market cap of $7.20 billion, a PE ratio of -194.09, a P/E/G ratio of 2.22 and a beta of 1.09. American Healthcare REIT, Inc. has a fifty-two week low of $22.64 and a fifty-two week high of $43.52. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48.

American Healthcare REIT (NYSE:AHR - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. The firm had revenue of $542.50 million during the quarter, compared to analysts' expectations of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business's revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Equities analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, July 18th. Stockholders of record on Monday, June 30th were issued a $0.25 dividend. The ex-dividend date of this dividend was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.3%. American Healthcare REIT's dividend payout ratio is -454.55%.

Insider Transactions at American Healthcare REIT

In related news, CIO Stefan K.L. Oh sold 3,860 shares of the firm's stock in a transaction on Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the sale, the executive owned 95,671 shares of the company's stock, valued at $3,453,723.10. This trade represents a 3.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Mark E. Foster sold 3,850 shares of the firm's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the sale, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their position. The disclosure for this sale can be found here. 0.92% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have commented on the company. KeyCorp raised their price objective on American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 11th. Robert W. Baird assumed coverage on American Healthcare REIT in a research note on Friday, July 18th. They set an "outperform" rating and a $41.00 price objective on the stock. Truist Financial raised their price objective on American Healthcare REIT from $44.00 to $46.00 and gave the stock a "buy" rating in a research note on Tuesday, August 26th. Royal Bank Of Canada raised their price objective on American Healthcare REIT from $39.00 to $45.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. Finally, Scotiabank restated an "outperform" rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company. According to data from MarketBeat.com, American Healthcare REIT currently has a consensus rating of "Buy" and a consensus price target of $41.89.

View Our Latest Analysis on AHR

American Healthcare REIT Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Articles

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.